These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10976611)

  • 41. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A mixed methods approach to delineating and understanding injection practices among clientele of a Victoria, British Columbia needle exchange program.
    Gibson EK; Exner H; Stone R; Lindquist J; Cowen L; Roth EA
    Drug Alcohol Rev; 2011 Jul; 30(4):360-5. PubMed ID: 21355916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV and Hepatitis C Virus Infection and Risk Behaviors Among Heterosexual, Bisexual, and Lesbian Women Who Inject Drugs in Australia.
    Iversen J; Dolan K; Ezard N; Maher L
    LGBT Health; 2015 Jun; 2(2):127-34. PubMed ID: 26790118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safer injection facility use and syringe sharing in injection drug users.
    Kerr T; Tyndall M; Li K; Montaner J; Wood E
    Lancet; 2005 Jul 23-29; 366(9482):316-8. PubMed ID: 16039335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City.
    Huong NT; Mundy G; Neukom J; Zule W; Tuan NM; Tam NM
    Harm Reduct J; 2015 May; 12():15. PubMed ID: 26024921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary syringe exchange among users of 23 California syringe exchange programs.
    Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
    Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of a syringe-exchange program on a decrease in the risk of HIV infection among intravenous narcotic abusers in the city of Rostov-on-Don].
    Saukhat SR; Vorontsov DV; Tormozova NM; Golubenko IA; Kravchenko VF; Poplavskaia TK; Ternovaia NM; Rabinovich VD; Orlov NV; Ryndich IV; Prokopenkova SA
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):89-92. PubMed ID: 10994120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study.
    Huo D; Ouellet LJ
    J Acquir Immune Defic Syndr; 2007 May; 45(1):108-14. PubMed ID: 17460474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
    Wodak A; Crofts N
    Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: "Syringe exchange and risk of infection with hepatitis B and C viruses".
    Voth EA
    Am J Epidemiol; 2000 Jan; 151(2):207-8. PubMed ID: 10645825
    [No Abstract]   [Full Text] [Related]  

  • 59. Anabolic steroid users identified by needle and syringe exchange contact.
    Morrison CL
    Drug Alcohol Depend; 1994 Oct; 36(2):153-5. PubMed ID: 7851283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Satellite needle distribution among injection drug users: policy and practice in two canadian cities.
    Tyndall MW; Bruneau J; Brogly S; Spittal P; O'Shaughnessy MV; Schechter MT
    J Acquir Immune Defic Syndr; 2002 Sep; 31(1):98-105. PubMed ID: 12352156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.